Developer docs
API playgroundTry for free, no card

Search company profiles

CureClick

Full company profile

uuid000j3k4

Namestring
CureClick
Legal namestring
Definitive Media Corp dba THREAD
Websiteurl
cureclick.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

THREAD, operated by Definitive Media Corp, is a US-based clinical research technology company that sells a no-code decentralized clinical trial (DCT) platform to pharmaceutical, biotechnology, and contract research organization (CRO) sponsors across the United States, the United Kingdom, Germany, France, Spain, and Italy. The platform consolidates twelve clinical trial technologies—eCOA and eDiaries, eConsent, telehealth virtual visits, voice/image/video capture, digital health technology sensors, eCRFs and eSource, engagement and retention, SSO, APIs and integrations, configurable data reporting, real-time analytics, and global cloud—into a single configurable system that supports site-based, hybrid, and fully decentralized study designs. The company bundles a scientific services arm around the software, most notably the Modus Outcomes patient-centered outcomes research (PCOR) team for endpoint selection and validation, and a Patient and HCP Listening capability powered by inVibe technology for systematic capture of patient and clinician voice.

The business operates on a two-stream revenue model: subscription-based access to the THREAD clinical trial platform and professional services revenue from consultative engagements including study design and operational support. Go-to-market is direct enterprise field sales with a consultative selling motion; pricing is quote-based rather than publicly disclosed, and the company uses 'Request a Demo' and 'Schedule a Quick Demo' as primary conversion paths. The platform is deployed on AWS global cloud infrastructure and is transactable via the AWS Marketplace, and it carries an enterprise-grade compliance stack including SOC 2 Type II, ISO 27001, GDPR, HIPAA, and FDA 21 CFR Part 11, complemented by the 2025 Digital Medicine Society (DiMe) Seal for Quality and Trust and an EcoVadis sustainability medal. THREAD sells horizontally across research types (digital health technology, MedTech, pediatrics, registries, Phase 2/3, Phase 3b/4 post-approval) and purposefully across therapeutic areas including cardiovascular and metabolic, dermatology, neurology and CNS, oncology, rare disease, cell and gene therapy, gastroenterology, hematology, immunology and rheumatology, infectious diseases, obesity and diabetes, ophthalmology, and pulmonology.

Short descriptiontext

THREAD, a US-based clinical research technology company, sells a no-code decentralized clinical trial platform unifying 12 trial technologies with consultative patient-centered outcomes research and patient-voice services for pharmaceutical, biotechnology, and CRO customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCosta Mesa, United States
HQ citystring
Costa Mesa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
decentralized clinical trials, electronic clinical outcomes, clinical research platform, patient-centered outcomes research, eCOA technology
Industry1 code
PRIMARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Decentralized Clinical Trial Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Research Technology Platform
TypeSubscription Recurring
Description

Subscription-based access to THREAD's no-code clinical research platform including 12 clinical trial technologies. The platform is offered as a comprehensive solution for study sponsors and CROs.

threadresearch.com
2Consultative Services
TypeProfessional Services
Description

Expert consulting services including study design, endpoint selection, patient-centered outcomes research (PCOR), and enablement services (Define and Support).

threadresearch.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

CureClick operates a no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth, eCRFs, voice/image/video capture, digital health technology, real-time analytics) into a single unified system. The platform is paired with consultative services including patient-centered outcomes research (PCOR) through Modus Outcomes and enablement services (Define and Support) for life science organizations, CROs, and academic research institutions. The company supports site-based, fully decentralized, or hybrid clinical studies across multiple countries and languages.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduce research study costs and timelines
+2 more records
Product overview1 text field

THREAD is a clinical research technology company offering a unified decentralized clinical trial (DCT) platform combining 12 clinical trial technologies. The platform operates on a modular architecture comprising a No-Code Platform for study configuration, multiple technology modules (eCOA and eDiaries, eConsent, Telehealth Virtual Visits, Voice/Image/Video Capture, Digital Health Technology/Sensors, eCRFs/eSource, Realtime Analytics), access capabilities (API and Integrations, Configurable SSO, Global Cloud, RWD and Tokenization), and consultative services (Modus Outcomes PCOR services, Enablement Services). The platform is powered by AI and integrates with AWS Marketplace for cloud deployment. The company also offers purpose-built solutions across therapeutic areas (Cardiovascular, Dermatology, Neurology/CNS, Oncology, Rare Disease) and research types (Digital Health Technology, MedTech, Pediatrics, Registries, Phase 2/3 Clinical Trials, Phase 3b/4 Post Approval Studies).

Product and service4 records
1THREAD Platform
CategoryClinical Trial Platform (SaaS)
Description

A comprehensive no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth virtual visits, eCRFs, voice/image/video capture, digital health technology, real-time analytics) for site-based, fully decentralized, or hybrid clinical studies. Built for life science organizations, CROs, and academic research institutions.

2Patient and HCP Listening
CategoryPatient Insights Solution
Description

A solution for engaging patients and healthcare providers in study design through structured listening sessions and co-creation methodologies, powered by inVibe technology. Enables study sponsors and CROs to collect and analyze real patient voices in a simple, systematic, and scalable way across the organization.

3Modus Outcomes (PCOR Services)
CategoryConsultative Services
Description

Patient-centered outcomes research (PCOR) professional services including endpoint selection, validation, and measurement expertise. Provides scientifically validated outcome measures grounded in the patient experience to optimize decision-making about the development, commercialization, and use of medical products.

4Consultative Services (Define and Support)
CategoryConsultative Services
Description

Enablement services offering study design (Define) and operational support throughout the research lifecycle for clinical trial execution, paired with the THREAD platform technology.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

AWS Partner with THREAD available on the AWS Marketplace. Platform runs on AWS cloud infrastructure providing global cloud capabilities, scalability, and reliability for clinical trial operations.

Strategic tierMinorTypeOthers
Description

DiMe awarded THREAD the DiMe Seal for Quality and Trust, recognizing excellence in digital medicine technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medidata's Rave EDC, eCOA, and DCT offerings compete head-to-head with THREAD for the same pharma/biotech and CRO sponsors running decentralized and hybrid studies.

TypeDirect peer
Description

Medable is a DCT-native platform offering eCOA, eConsent, telehealth, and remote monitoring — directly overlapping THREAD's modular DCT stack.

TypeDirect peer
Description

Science 37 pioneered fully decentralized trial execution and is a direct DCT competitor to THREAD, particularly for sponsor-led direct-to-patient studies.

TypeDirect peer
Description

Castor provides a configurable EDC and DCT platform for academic and commercial sponsors, competing with THREAD's no-code configuration layer and eCRF/eSource module.

TypeDirect peer
Description

Clario is a major eCOA and DCT technology provider serving pharma/biotech, directly overlapping THREAD's eCOA, eDiaries, and endpoint capture capabilities.

TypeDirect peer
Description

Signant Health provides eCOA, eConsent, and patient engagement solutions for clinical trials — a direct competitor to THREAD's Patient and HCP Listening and eCOA modules.

TypeDirect peer
Description

YPrime offers eCOA, IRT, and DCT-configurable clinical trial technology with a comparable modular platform approach to THREAD's no-code configuration.

TypeBroad incumbent
Description

Veeva's Vault CDB, Vault EDC, and broader clinical suite compete with THREAD as part of a wider enterprise clinical platform targeting large pharma sponsors.

9Oracle Health Sciences (Clinical One / Inform)
TypeBroad incumbent
Description

Oracle's Clinical One and legacy Phase One/Rave-adjacent EDC compete with THREAD for enterprise trial platforms, particularly with large pharma running complex global studies.

TypeBroad incumbent
Description

IQVIA combines CRO services with its own DCT and eCOA technology stack, competing with THREAD both as a technology vendor and as a service provider to the same sponsor base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CureClick

Decentralized Clinical Trial Platformcureclick.com

THREAD, a US-based clinical research technology company, sells a no-code decentralized clinical trial platform unifying 12 trial technologies with consultative patient-centered outcomes research and patient-voice services for pharmaceutical, biotechnology, and CRO customers globally.

What CureClick does

THREAD, operated by Definitive Media Corp, is a US-based clinical research technology company that sells a no-code decentralized clinical trial (DCT) platform to pharmaceutical, biotechnology, and contract research organization (CRO) sponsors across the United States, the United Kingdom, Germany, France, Spain, and Italy. The platform consolidates twelve clinical trial technologies—eCOA and eDiaries, eConsent, telehealth virtual visits, voice/image/video capture, digital health technology sensors, eCRFs and eSource, engagement and retention, SSO, APIs and integrations, configurable data reporting, real-time analytics, and global cloud—into a single configurable system that supports site-based, hybrid, and fully decentralized study designs. The company bundles a scientific services arm around the software, most notably the Modus Outcomes patient-centered outcomes research (PCOR) team for endpoint selection and validation, and a Patient and HCP Listening capability powered by inVibe technology for systematic capture of patient and clinician voice.

The business operates on a two-stream revenue model: subscription-based access to the THREAD clinical trial platform and professional services revenue from consultative engagements including study design and operational support. Go-to-market is direct enterprise field sales with a consultative selling motion; pricing is quote-based rather than publicly disclosed, and the company uses 'Request a Demo' and 'Schedule a Quick Demo' as primary conversion paths. The platform is deployed on AWS global cloud infrastructure and is transactable via the AWS Marketplace, and it carries an enterprise-grade compliance stack including SOC 2 Type II, ISO 27001, GDPR, HIPAA, and FDA 21 CFR Part 11, complemented by the 2025 Digital Medicine Society (DiMe) Seal for Quality and Trust and an EcoVadis sustainability medal. THREAD sells horizontally across research types (digital health technology, MedTech, pediatrics, registries, Phase 2/3, Phase 3b/4 post-approval) and purposefully across therapeutic areas including cardiovascular and metabolic, dermatology, neurology and CNS, oncology, rare disease, cell and gene therapy, gastroenterology, hematology, immunology and rheumatology, infectious diseases, obesity and diabetes, ophthalmology, and pulmonology.

CureClick firmographics

Firmographics
Name
CureClick
Legal name
Definitive Media Corp dba THREAD
Website
https://cureclick.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
THREAD, a US-based clinical research technology company, sells a no-code decentralized clinical trial platform unifying 12 trial technologies with consultative patient-centered outcomes research and patient-voice services for pharmaceutical, biotechnology, and CRO customers globally.
Ownership category
akta.pro rank

CureClick industry classification

Industry
Product category
Decentralized Clinical Trial Platform
NAICS
Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Decentralized clinical trials
  • Electronic clinical outcomes
  • Clinical research platform
  • Patient-centered outcomes research
  • ECOA technology

Where CureClick is headquartered

Location

Headquarters

HQ city
Costa Mesa
HQ country
United States
HQ region
North America

Markets served

CureClick business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Clinical Research Technology Platform: Subscription-based access to THREAD's no-code clinical research platform including 12 clinical trial technologies. The platform is offered as a comprehensive solution for study sponsors and CROs.
  2. Consultative Services: Expert consulting services including study design, endpoint selection, patient-centered outcomes research (PCOR), and enablement services (Define and Support).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

CureClick product offering

Product offering

Core offering

CureClick operates a no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth, eCRFs, voice/image/video capture, digital health technology, real-time analytics) into a single unified system. The platform is paired with consultative services including patient-centered outcomes research (PCOR) through Modus Outcomes and enablement services (Define and Support) for life science organizations, CROs, and academic research institutions. The company supports site-based, fully decentralized, or hybrid clinical studies across multiple countries and languages.

Product overview

THREAD is a clinical research technology company offering a unified decentralized clinical trial (DCT) platform combining 12 clinical trial technologies. The platform operates on a modular architecture comprising a No-Code Platform for study configuration, multiple technology modules (eCOA and eDiaries, eConsent, Telehealth Virtual Visits, Voice/Image/Video Capture, Digital Health Technology/Sensors, eCRFs/eSource, Realtime Analytics), access capabilities (API and Integrations, Configurable SSO, Global Cloud, RWD and Tokenization), and consultative services (Modus Outcomes PCOR services, Enablement Services). The platform is powered by AI and integrates with AWS Marketplace for cloud deployment. The company also offers purpose-built solutions across therapeutic areas (Cardiovascular, Dermatology, Neurology/CNS, Oncology, Rare Disease) and research types (Digital Health Technology, MedTech, Pediatrics, Registries, Phase 2/3 Clinical Trials, Phase 3b/4 Post Approval Studies).

Differentiator

Problem solved

Functional benefit

Products and services

  • THREAD Platform A comprehensive no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth virtual visits, eCRFs, voice/image/video capture, digital health technology, real-time analytics) for site-based, fully decentralized, or hybrid clinical studies. Built for life science organizations, CROs, and academic research institutions.
  • Patient and HCP Listening A solution for engaging patients and healthcare providers in study design through structured listening sessions and co-creation methodologies, powered by inVibe technology. Enables study sponsors and CROs to collect and analyze real patient voices in a simple, systematic, and scalable way across the organization.
  • Modus Outcomes (PCOR Services) Patient-centered outcomes research (PCOR) professional services including endpoint selection, validation, and measurement expertise. Provides scientifically validated outcome measures grounded in the patient experience to optimize decision-making about the development, commercialization, and use of medical products.
  • Consultative Services (Define and Support) Enablement services offering study design (Define) and operational support throughout the research lifecycle for clinical trial execution, paired with the THREAD platform technology.

Quantifiable outcome

  • Reduce research study costs and timelines
  • +2 more outcomes

Companies that use CureClick

Customer profile

Segments3 records

Ideal customer profiles3 records

CureClick technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

CureClick partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • AWS (Amazon Web Services)coreTechnology or IntegrationAWS Partner with THREAD available on the AWS Marketplace. Platform runs on AWS cloud infrastructure providing global cloud capabilities, scalability, and reliability for clinical trial operations.
  • Digital Medicine Society (DiMe)minorOthersDiMe awarded THREAD the DiMe Seal for Quality and Trust, recognizing excellence in digital medicine technology.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

CureClick competitors and assessment

Company assessment

Direct peers

  • Medidata (Dassault Systèmes): Medidata's Rave EDC, eCOA, and DCT offerings compete head-to-head with THREAD for the same pharma/biotech and CRO sponsors running decentralized and hybrid studies.
  • Medable: Medable is a DCT-native platform offering eCOA, eConsent, telehealth, and remote monitoring — directly overlapping THREAD's modular DCT stack.
  • Science 37 (now Evidera/PPD): Science 37 pioneered fully decentralized trial execution and is a direct DCT competitor to THREAD, particularly for sponsor-led direct-to-patient studies.
  • Castor: Castor provides a configurable EDC and DCT platform for academic and commercial sponsors, competing with THREAD's no-code configuration layer and eCRF/eSource module.
  • Clario (ERT / Bioclinica): Clario is a major eCOA and DCT technology provider serving pharma/biotech, directly overlapping THREAD's eCOA, eDiaries, and endpoint capture capabilities.
  • Signant Health: Signant Health provides eCOA, eConsent, and patient engagement solutions for clinical trials — a direct competitor to THREAD's Patient and HCP Listening and eCOA modules.
  • YPrime: YPrime offers eCOA, IRT, and DCT-configurable clinical trial technology with a comparable modular platform approach to THREAD's no-code configuration.

Broad incumbents

  • Veeva Systems: Veeva's Vault CDB, Vault EDC, and broader clinical suite compete with THREAD as part of a wider enterprise clinical platform targeting large pharma sponsors.
  • Oracle Health Sciences (Clinical One / Inform): Oracle's Clinical One and legacy Phase One/Rave-adjacent EDC compete with THREAD for enterprise trial platforms, particularly with large pharma running complex global studies.
  • IQVIA: IQVIA combines CRO services with its own DCT and eCOA technology stack, competing with THREAD both as a technology vendor and as a service provider to the same sponsor base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

CureClick social profiles

Digital presence

CureClick compliance and trust

Trust signal

Compliance6 records

CureClick financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CureClick leadership team

Management profile

Number of profiles

CureClick funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CureClick M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CureClick

What does CureClick do?

CureClick operates a no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth, eCRFs, voice/image/video capture, digital health technology, real-time analytics) into a single unified system. The platform is paired with consultative services including patient-centered outcomes research (PCOR) through Modus Outcomes and enablement services (Define and Support) for life science organizations, CROs, and academic research institutions. The company supports site-based, fully decentralized, or hybrid clinical studies across multiple countries and languages.

Is CureClick a public or private company?

CureClick is a private company. It is classified as unknown and is currently operating.

When was CureClick founded?

CureClick was founded in 2014. It employs 1 to 10 people.

Where is CureClick based?

CureClick is headquartered in Costa Mesa, United States, in the North America region.

How does CureClick make money?

Two revenue lines are on record. Clinical Research Technology Platform is the primary driver. The others are consultative Services.

Who are CureClick's main competitors?

Direct peers on record are Medidata (Dassault Systèmes), Medable, Science 37 (now Evidera/PPD), Castor, Clario (ERT / Bioclinica), Signant Health and YPrime. Broad incumbents are Veeva Systems, Oracle Health Sciences (Clinical One / Inform) and IQVIA.

Does CureClick have an API?

Yes. THREAD provides an API and integrations capability as part of its platform access layer, enabling connectivity with other systems. Available under the 'Access' section of the platform: 'API and Integrations' (/one-decentralized-platform/apis). Developer documentation is at www.threadresearch.com/one-decentralized-platform/apis.

What industry is CureClick in?

CureClick's product category is Decentralized Clinical Trial Platform. Its primary akta.pro industry code is HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HIT ConsultantTHREAD Acquires Clinical Trial Recruitment Solution CureClickTHREAD acquired CureClick, a crowdsourcing platform for clinical trial recruitment, adding its network of over 6,500 ambassadors and 75 disease states. The integration will automate enrollment pathways in THREAD's decentralized clinical trials platform. Financial terms were not disclosed.PR NewswireTHREAD Acquires CureClick, Optimizing the Pathway from Clinical Trial Awareness to AccessTHREAD has acquired CureClick, a crowdsourcing platform designed to accelerate clinical trial awareness and participation. This acquisition positions THREAD as a leading provider of decentralized clinical trials (DCTs) by integrating CureClick's network of over 6,500 ambassadors into its existing platform. The move aims to streamline the pathway from patient education to enrollment, enhancing diversity and efficiency in global research studies.Wayback MachineTHREAD Acquires CureClick, Optimizing the Pathway from Clinical Trial Awareness to AccessTHREAD has acquired CureClick, a crowdsourcing platform designed to accelerate clinical trial awareness and participation, to enhance its decentralized clinical trials (DCT) offerings. This acquisition integrates CureClick’s network of over 6,500 ambassadors into THREAD's platform, aiming to streamline patient enrollment and improve diversity in global research studies.AiThorityCureClick Reshapes Clinical Recruitment Space Through Appointment of Nico Coetzee as Chief Marketing OfficerCureClick appointed Nico Coetzee as Chief Marketing Officer to lead its clinical recruitment marketing efforts. Coetzee brings over 20 years of healthcare technology experience, including roles at KPI Agency and inVentiv Health. The appointment aims to scale the company's influencer-powered patient recruitment model.PR NewswireCureClick Reshapes Clinical Recruitment Space Through Appointment of Nico Coetzee as Chief Marketing OfficerCureClick, a digital health company operating a crowdsourcing platform for clinical trial recruitment, announced the appointment of Nico Coetzee as Chief Marketing Officer. Coetzee brings more than 20 years of healthcare technology experience, most recently serving as co-founder and global CEO of KPI Agency, and previously holding leadership positions across markets in Dubai, London, Amsterdam, and South Africa. The appointment is intended to position the company for scaling its influencer-powered patient recruitment model.AiThorityTHREAD and CureClick Partner to Accelerate Recruitment for Decentralized Clinical TrialsTHREAD and CureClick announced a partnership to use CureClick's network of over 100,000 patient activists to recruit for decentralized clinical trials. The collaboration aims to increase enrollment, retention, and satisfaction by having influencers highlight trials on social media. THREAD's platform includes an automated recruitment and onboarding solution.PR NewswireTHREAD and CureClick Partner to Accelerate Recruitment for Decentralized Clinical TrialsTHREAD and CureClick announced a partnership to use social media influencers to recruit participants for decentralized clinical trials. CureClick's network of over 100,000 patient activists will deliver eligible participants to THREAD's automated recruitment and onboarding solution. The collaboration aims to improve enrollment, retention, and satisfaction rates.PR NewswireAlchemy Factory Founder and Chief Alchemist Fabio Gratton Earns Repeat Recognition as Inspiring Life Sciences Leader in 2019 PharmaVOICE 100Alchemy Factory founder Fabio Gratton earned repeat recognition as a member of the PharmaVOICE 100, an annual list recognizing the most influential and inspirational leaders in the life sciences industry, marking his third appearance on the list following 2009 and 2016. Gratton's entrepreneurial portfolio includes multiple startups under the Alchemy Factory umbrella, such as CureClick, SONIC Health, inVibe Labs, Carma Project, and BryteLife, which collectively address unmet needs across health, research, and consumer sectors. He has also established a $50,000 philanthropic angel fund to support early-stage companies focused on societal rather than financial gain.PR NewswireWEGO Health Partners with CureClick to Streamline and Accelerate Clinical Trial RecruitmentWEGO Health partnered with CureClick to make its patient influencers available through CureClick's clinical trial recruiting platform. The partnership aims to reduce time, costs, and friction in enrollment, leveraging WEGO's 100,000+ vetted patient leaders. It addresses recruitment challenges, including two-thirds of sites missing enrollment goals.